© 2024 — All rights reserved for arthrogenius site
About Us
Fast-Tracking Osteoarthritis Detection with AI
Arthrogenius is transforming how osteoarthritis (OA) is detected. Our AI platform analyzes X-ray images to identify early signs of osteoarthritis in joints, a condition affecting over 540 million people globally. By automating initial X-ray analyses, we enable up to 30% faster detection, improving patient care and minimizing long-term damage.
Arthrogenius
Transforming Osteoarthritis Detection
with AI Precision and Speed
Why Choose us
How It Works
Our AI platform seamlessly integrates with existing X-ray systems. X-ray images are securely transmitted to our platform for analysis. Our AI algorithms then identify potential early signs of osteoarthritis, such as narrowing joint space. Results are promptly communicated to healthcare providers, enabling faster diagnosis and early intervention
Advantages of artificial intelligence
In the diagnosis of atherosclerosis
analyzed
Number of clients
89% (in identifying various arthritic conditions)
Number Of Hospitals
.01
Revenue generated:
€28,000 in the first 6 months in Iran
.02
Research dataset:
3,900 meticulously labeled X-rays used for AI training
.03
Cost savings
Potential €1,500 saved per patient with early intervention
.04
Patient satisfaction:
92% of patients report satisfaction with faster diagnoses
Our Team
Meet the Experts Behind Arthrogenius
Our journey has been enriched by the guidance of experienced mentors who have provided invaluable insights and support:
Testimonials
What Our Client’s Say
Arthrogenius has significantly improved our ability to detect osteoarthritis early, leading to better outcomes for our patients.
collaborations
Join Our Mission to Transform Osteoarthritis Care
The accelerators which have helped us along the way…
1
Accelerating Arthrogenius's Path to Global Success
Iran Science and Technology Park
Arthrogenius's journey from concept to reality was significantly accelerated by the invaluable support of the Iran Science and Technology Park (ISTT) (https://itechpark.ir/en/). As a leading technology incubator in Iran, ISTT provided us with essential resources, including office space at their vibrant headquarters, fostering collaboration and networking opportunities. Furthermore, their non-dilutive grant of €4,000 in late 2022 was instrumental in covering critical expenses and propelling our development forward. ISTT's mentorship and guidance were crucial in navigating the complexities of the Iranian startup ecosystem, ultimately positioning Arthrogenius for success in the global market.
1
A Crucial Catalyst in Arthrogenius's Early Success
Sharif University of Technology Science and Technology Park
Arthrogenius's early development was significantly aided by the Sharif University of Technology Science and Technology Park (SUTSTP) (https://techpark.sharif.ir/en/). As a renowned hub for innovation and entrepreneurship in Iran, SUTSTP provided Arthrogenius with a nurturing environment to refine its technology and business strategy. Through SUTSTP's mentorship programs and networking opportunities, we gained valuable insights and connections within the Iranian healthcare and technology sectors, which were crucial in establishing our initial partnerships and securing early-stage funding.
Our Advisors
Dr. Mojtaba Lashkarbolouki
Arthrogenius has significantly improved our ability to detect osteoarthritis early, leading to better outcomes for our patients.
Hamed Taghizade
A seasoned healthcare professional with a deep understanding of Iran's regulatory landscape. Dr. Lashkarbolouki played a pivotal role in ensuring our platform met all necessary requirements and provided strategic guidance for our initial growth
Blog
Read our latest blog
Ready to revolutionize your arthritis detection?
Contact us for a demo or free trial